Click for more information

laboratory
services

Key Subsectors

Diagnostic Testing

Regulatory Testing

Manufacturing Support

Current Investments

Bako

Current Investments

GENEWIZ

Current Investments

Genoptix

Prior Investments

Accuratus Lab Services

Prior Investments

Signature Genomic Laboratories

Prior Investments

Viracor-IBT Laboratories

Ampersand Case Study: Viracor-IBT Laboratories

Close
laboratory
products

Key Subsectors

Scientific Products

Diagnostic Products

Specialty Distribution

Current Investments

Gyros Protein Technologies

Prior Investments

Aclara Biosciences

Prior Investments

Assay Designs

Prior Investments

Magellan Diagnostics

Prior Investments

TriPath Imaging (Nasdaq: TPTH)

Close
contract
manufacturing

Key Subsectors

Medical Devices and Components

Nutritionals and Ingredients

Current Investments

Confluent Medical Technologies

Current Investments

Corpus Medical

Current Investments

Elite One Source Nutrisciences

Current Investments

Innovative Food Processors

Prior Investments

MedVenture Technology

Prior Investments

Ortho Organizers

Close
pharma
services

Key Subsectors

Pre Clinical Services

Clinical Trial Support

Outsourced Production

Current Investments

Avista Pharma Solutions

Current Investments

Brammer Bio

Current Investments

LakePharma

Prior Investments

Agilux Laboratories

Prior Investments

BioClinica

Prior Investments

ChanTest

Prior Investments

CoreLab Partners

Prior Investments

CRI Lifetree

Close
specialty
pharma

Key Subsectors

Complex Manufacturing

Specialty Distribution

Current Investments

Bioventus

Current Investments

CutisPharma

Current Investments

Roadrunner Pharmacy

Prior Investments

Talecris Biotherapeutics (Grifols, SA)

Prior Investments

Victory Pharma

Close
healthcare
services

Key Subsectors

Behavioral Health

Home Health and Hospice Services

Provider Services

Wellness

Animal Health

Close

Target Healthcare Sectors

Ampersand has over two decades of experience in helping build middle market healthcare companies into market leaders.  We focus on EBITDA-positive companies that provide products or services within several key healthcare sectors, including laboratory testing services, laboratory products, contract manufacturing, pharma services, specialty pharma and healthcare services.  Ampersand brings significant prior experience to each of these sectors, allowing us to partner with entrepreneurs in taking their companies to the next level.

Investment Criteria

Company Size

Typically $10 to $100 million of revenue

Investment Size

$10 to $30 million of equity
Use of leverage when appropriate

Ownership

Either majority or minority positions

Role

First institutional investor

Use of Capital

Business expansion / growth equity
Recapitalizations / shareholder equity
Management buyouts
Corporate divestitures

Geography

North America

Target Healthcare Sectors

Laboratory Services
Laboratory Products
Contract Manufacturing
Pharma Services
Specialty Pharma
Healthcare Services